RESUMEN
Plasma alpha-tocopherol (vit E) and blood selenium (Se) concentrations in February were determined in samples from 314 dairy cows in Norway, selected to provide a representative subset of the Norwegian dairy cow population. Each sample was followed by a questionnaire with information about feeding of the cow at the time of sampling. The results were correlated to herd data and to calving and health data for each cow from the Norwegian Dairy Herd Recording System and the Norwegian Cattle Health Recording System. The mean concentrations were 6.9 microg vit E per ml plasma and 0.16 microg Se per g blood. Both levels were highest in mid lactation. Plasma vit E varied with the amount of silage fed to the cow, while blood Se varied with the amount of concentrates and mineral supplements, and with geographical region. No differences in vit E or Se levels were found between cows with recorded treatments for mastitis, parturient paresis or reproductive disorders in the lactation during or immediately prior to sampling, and those without such treatments. For ketosis, a small difference in blood Se was found between the groups with or without recorded treatments. It is concluded that winter-fed lactating cows in Norway had an adequate plasma level of vit E and a marginal-to-adequate level of Se.
Asunto(s)
Alimentación Animal , Fenómenos Fisiológicos Nutricionales de los Animales , Bovinos/sangre , Selenio/sangre , Vitamina E/sangre , Animales , Industria Lechera , Femenino , Geografía , Lactancia/metabolismo , Noruega , Periodo Posparto/sangre , EmbarazoRESUMEN
Metomidate was administered to halibut (Hippoglossus hippoglossus) and turbot (Scophthalmus maximus) intravenously at a dose of 3 mg/kg bodyweight, as a bath treatment at a dose of 9 mg/L water for 5 min to study the disposition of metomidate, and as bath treatment (9 mg/L) for 10 min to study the absorption and effect of metomidate on respiration and balance/motor control. Additionally, turbot were given metomidate orally at a dose of 7 mg/kg. The studies were performed in seawater at a temperature of 10.3 +/- 0.4 degrees C (halibut) and 18.0 +/- 0.3 degrees C (turbot). Pharmacokinetic modeling of the data showed that metomidate had shorter elimination half-life and higher plasma concentrations in turbot compared with halibut, both species displaying a rapid uptake, distribution and excretion. Following intravenous administration, the volumes of distribution at steady state (Vd(ss)) were 0.21 L/kg (halibut) and 0.44 L/kg (turbot). Plasma clearances (Cl) were 0.099 L/h.kg in halibut and 0.26 L/h.kg in turbot and the elimination half-lives (t(1/2)lambdaz) were calculated to be 5.8 h and 2.2 h in halibut and turbot, respectively. Mean residence times (MRT) were 2.2 h in halibut and 1.7 h in turbot. Following oral administration, the t(1/2)lambdaz was 3.5 h in turbot. The maximum plasma concentration (Cmax) was 7.8 mg/L in turbot 1 h after administration. The oral bioavailability (F) was calculated to 100% in turbot. Following 5 min bath the maximum plasma concentrations (Cmax), which were observed immediately after end of the bath, were 9.5 mg/L and 13.3 mg/L in halibut and turbot, respectively. Metomidate rapidly immobilized the fish, with respiratory depression, reduced heart rate, and loss of balance/motor control within 1 min (mean). Recovery was slow, with resumed balance/motor control after 26.4 min. Opercular respiration movements were resumed more rapidly with a recorded mean of 1.7 min. Oral administration was demonstrated to be a way of immobilizing fish, for example in large aquariums, without exposing them to unwanted stress.
Asunto(s)
Anestésicos/farmacología , Anestésicos/farmacocinética , Etomidato/análogos & derivados , Etomidato/farmacología , Etomidato/farmacocinética , Peces Planos/metabolismo , Administración Oral , Anestésicos/administración & dosificación , Anestésicos/sangre , Animales , Disponibilidad Biológica , Etomidato/administración & dosificación , Etomidato/sangre , Lenguado/metabolismo , Inmersión , Inyecciones Intravenosas/veterinaria , Actividad Motora/efectos de los fármacos , Absorción Cutánea , Especificidad de la EspecieRESUMEN
The pharmacokinetics of two potent alpha 2-adrenoceptor agents that can be used for immobilization (medetomidine) and reversal (atipamezole) of the sedation in mammals, were studied in three reindeer (Rangifer tarandus tarandus) in winter and again in summer. Medetomidine (60 micrograms/kg) was injected intravenously (i.v.), followed by atipamezole (300 micrograms/kg) intravenously 60 min later. Drug concentrations in plasma were measured by HPLC. The administration of atipamezole resulted in an immediate 2.5-3.5 fold increase in the medetomidine concentration in plasma. Clearance for medetomidine (median 19.3 mL/min.kg) was lower than clearance for atipamezole (median 31.0 mL/min.kg). The median elimination half-lives of medetomidine and atipamezole in plasma were 76.1 and 59.9 min, respectively. The animals became resedated 0.5-1 h after the reversal with atipamezole. Resedation may be explained by the longer elimination half-life of medetomidine compared to atipamezole.
Asunto(s)
Antagonistas Adrenérgicos alfa/farmacología , Conducta Animal/efectos de los fármacos , Ciervos/sangre , Hipnóticos y Sedantes/antagonistas & inhibidores , Imidazoles/antagonistas & inhibidores , Imidazoles/farmacología , Antagonistas Adrenérgicos alfa/farmacocinética , Animales , Área Bajo la Curva , Relación Dosis-Respuesta a Droga , Femenino , Semivida , Hipnóticos y Sedantes/sangre , Hipnóticos y Sedantes/farmacocinética , Imidazoles/sangre , Imidazoles/farmacocinética , Inyecciones Intravenosas/veterinaria , Medetomidina , Estaciones del AñoRESUMEN
A method well suited for screening large numbers of plasma samples for ochratoxin A is presented. Proteins were precipitated with methanol and the supernatant diluted with 0.01 M phosphoric acid before 1 ml extract was injected into a high-performance liquid chromatograph (HPLC). The extract was further cleaned up and pre-concentrated on a polystyrene-divinylbenzene precolumn. After column-switching, the sample was chromatographed on a C18 analytical column, and ochratoxin A was detected with a fluorescence spectrophotometer, either directly or after postcolumn pH shift. The detection limit was 0.10 ng ochratoxin A/ml plasma. The method was used to determine the ochratoxin A concentration in 216 samples of swine plasma. They were collected from different herds in June 1991 from ten slaughterhouses, located in different parts of Norway. Eighty-two percent of the samples contained > or = 0.10 ng ochratoxin A/ml plasma while 0.9% contained > or = 5.0 ng/ml.